Evaluation of Analgesia Nociception Index (ANI) During Propofol/Remifentanil and Sevoflurane/Remifentanil Anesthesia
- Conditions
- General Anaesthesia
- Interventions
- Procedure: tetanic stimulation
- Registration Number
- NCT01522508
- Lead Sponsor
- University Hospital Schleswig-Holstein
- Brief Summary
The aim of this prospective randomized study was to evaluate the ability of the new Analgesia Nociception Index ANI, derived by heart rate variability, to detect painful stimulation during either propofol or sevoflurane anesthesia and changing remifentanil concentrations.
- Detailed Description
Monitoring Antinociception during general anesthesia is still a big challenge in the field and has not become clinical routine yet. Recently, for the Surgical Pleth Index SPI a benefit for the patient in terms of reduction of remifentanil use, less unwanted effects and shorter recovery from anesthesia was reported. However, there are new variables like the ANI that are developed to measure antinociception during anesthesia.
In the present study the investigators want to evaluate, whether ANI detects a painful tetanic stimulus during general anesthesia using propofol or sevoflurane and different concentrations of remifentanil.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- age between 18- 65 years,
- ASA physical status I or II,
- elective surgery in general anesthesia planned,
- written informed consent
- pregnancy,
- history of cardiac arrhythmia,
- presents of any neuromuscular or neurologic disease,
- use of CNS-active medication or abuse of alcohol/illicit drugs -
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description sevoflurane/remifentanil tetanic stimulation patients receive standardized sevoflurane and changing remifentanil concentrations propofol/remifentanil tetanic stimulation patients receive standardized propofol and changing remifentanil concentrations
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Kiel, Dept. of Anesthesiology and Intensive Care Med.
🇩🇪Kiel, Germany